These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7880450)

  • 1. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.
    Cappendijk SL; Fekkes D; Dzoljic MR
    Behav Brain Res; 1994 Nov; 65(1):117-9. PubMed ID: 7880450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat.
    Sharpe LG; Jaffe JH
    Neuroreport; 1990 Sep; 1(1):17-9. PubMed ID: 2129850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor.
    Glick SD; Rossman K; Rao NC; Maisonneuve IM; Carlson JN
    Neuropharmacology; 1992 May; 31(5):497-500. PubMed ID: 1528400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine dependent rat.
    Sharpe L; Jaffe J
    NIDA Res Monogr; 1990; 105():477. PubMed ID: 1876088
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice.
    Francés B; Gout R; Cros J; Zajac JM
    Fundam Clin Pharmacol; 1992; 6(8-9):327-32. PubMed ID: 1292965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
    Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norharman and alcohol-dependency in male Wistar rats.
    Fekkes D; Bernard BF; Cappendijk SL
    Eur Neuropsychopharmacol; 2004 Oct; 14(5):361-6. PubMed ID: 15336296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats.
    Cappendijk SL; Duval SY; de Vries R; Dzoljic MR
    Neurosci Lett; 1995 Jan; 183(1-2):67-70. PubMed ID: 7538210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
    Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
    Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats.
    Han JS; Zhang RL
    Drug Alcohol Depend; 1993 Jan; 31(2):169-75. PubMed ID: 8382148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome.
    Malin DH; Murray JB; Crucian GP; Schweitzer FC; Cook RE; Skolnick MH
    Biol Psychiatry; 1988 Dec; 24(8):886-90. PubMed ID: 2852967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents.
    Mash DC; Ameer B; Prou D; Howes JF; Maillet EL
    J Psychopharmacol; 2016 Jul; 30(7):688-97. PubMed ID: 27044509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
    Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of precipitated withdrawal in rats acutely dependent on morphine.
    Ramabadran K
    Jpn J Pharmacol; 1985 Apr; 37(4):307-16. PubMed ID: 2989597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
    Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
    Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.